Angio-associated migratory cell protein (AAMP) interacts with cell division cycle 42 (CDC42) and enhances migration and invasion in human non-small cell lung cancer cells.
Angio-associated migratory cell protein (AAMP) interacts with cell division cycle 42 (CDC42) and enhances migration and invasion in human non-small cell lung cancer cells.
复制标题
血管相关迁移细胞蛋白 (AAMP) 与细胞分裂周期 42 (CDC42) 相互作用,增强人非小细胞肺癌细胞的迁移和侵袭。
DOI:
10.1016/j.canlet.2020.11.050
复制
发表时间:
2021
期刊:
影响因子:
9.7
通讯作者:
Su Ling
中科院分区:
文献类型:
--
作者:
Yao Shun;Shi Feifei;Mu Ning;Li Xiaopeng;Ma Guilin;Wang Yingying;Sun Xiaoyang;Liu Xiangguo;Su Ling
Angio-associated migratory cell protein (AAMP) is considered a pro-tumor protein, which contributes to angiogenesis, proliferation, adhesion, and other biological activities. Although AAMP is known to facilitate the motility of breast cancer cells and smooth muscle cells by regulating ras homolog family member A (RHOA) activity, the function of AAMP in the metastasis of non-small cell lung cancer (NSCLC) cells still remains unknown. In the present study, AAMP was upregulated in non-small cell lung carcinoma, and was found to promote migration and invasion in NSCLC cells. Further experiments demonstrated that AAMP interacted with cell division cycle 42 (CDC42) and promoted its activation, resulting in the formation of cellular protrusions. Subsequently, we found that AAMP enhanced CDC42 activation by impairing the combination of rho GTPase activating protein 1 (ARHGAP1) and CDC42. Taken together, we revealed and elucidated the critical role of AAMP in the migration and invasion of NSCLC cells and presented a new potential target for lung cancer therapy.